Fecal and Serum Calprotectin Concentrations in Cats With Chronic Enteropathies Before and During Treatment
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.70067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Dimitra A Karra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Medicine, Faculty of Veterinary Science, University of Thessaly, Karditsa, Greece. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, Feces, Cat Diseases. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Chronic enteropathies (CE) are common in cats. Reliable biomarkers that can distinguish different causes and predict or monitor responses to treatment are currently lacking. Hypothesis/Objectives Evaluate calprotectin concentrations in serum and feces as potential biomarkers in cats with CE. Animals Forty-three cats with either chronic inflammatory enteropathy (CIE; n = 25) or small cell gastrointestinal lymphoma (SCGL; n = 18) and 36 healthy cats were prospectively enrolled.
Methods
Fecal and serum calprotectin concentrations were determined before and during treatment. Cats with CIE were treated with diet, prednisolone, or diet and prednisolone, and cats with SCGL were treated with prednisolone plus chlorambucil with or without diet.
Results
Compared to controls, fecal calprotectin concentration was significantly higher in cats with CE (median, ≤ 161 ng/g; range, ≤ 161–2827 vs. median, ≤ 161 ng/g; range, ≤ 161–790; p = 0.01). No significant differences were found in fecal (median ≤ 161 ng/g; range, ≤ 161–1920 vs. median, 189 ng/g; range, ≤ 161–2827; p = 0.3) or serum calprotectin (median, ≤ 1291 mg/L; range, ≤ 1291–15 358 vs. median, ≤ 1291 mg/L; range, ≤ 1291–6422; p = 0.99) between cats with CIE and cats with SCGL. Fecal calprotectin was significantly decreased after treatment in cats with CE (median, ≤ 161 ng/g; range, ≤ 161–1897 vs. median, ≤ 161 ng/g; range, ≤ 161–656; p = 0.02).
Conclusions
Fecal calprotectin concentration might be a good biomarker for diagnosis and treatment monitoring for a subset of cats with CE. Serum calprotectin concentrations do not seem to be useful for diagnosis or treatment monitoring in cats with CE. Neither fecal nor serum calprotectin concentrations could differentiate cats with CIE from cats with SCGL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic of Medicine, Faculty of Veterinary Science, University of Thessaly, Karditsa, Greece.
- Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas, USA.
- Newman Specialty VetPath, Hicksville, New York, USA.
ORCID-Profile: Dimitra A Karra, Jonathan A Lidbury, Jan S Suchodolski, Jeorg M Steiner, Panagiotis G Xenoulis
Zitieren
APA
Karra, D. A., Lidbury, J. A., Suchodolski, J. S., Pitropaki, M., Newman, S., Steiner, J. M., & Xenoulis, P. G. (2025). Fecal and Serum Calprotectin Concentrations in Cats With Chronic Enteropathies Before and During Treatment. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70067
Vancouver
Karra DA, Lidbury JA, Suchodolski JS, Pitropaki M, Newman S, Steiner JM, et al. Fecal and Serum Calprotectin Concentrations in Cats With Chronic Enteropathies Before and During Treatment. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70067
BibTeX
@article{Karra2025,
author = {Karra, Dimitra A and Lidbury, Jonathan A and Suchodolski, Jan S and Pitropaki, Matina and Newman, Shelley and Steiner, Jeorg M and Xenoulis, Panagiotis G},
title = {Fecal and Serum Calprotectin Concentrations in Cats With Chronic Enteropathies Before and During Treatment},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.70067}
}
EUVIMED